Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Ettinger, DS; Wood, DE; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; D'Amico, TA; DeCamp, M; Dilling, TJ ...
Published in: J Natl Compr Canc Netw
May 2022
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2022
Volume
20
Issue
5
Start / End Page
497 / 530
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Medical Oncology
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., … Hughes, M. (2022). Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 20(5), 497–530. https://doi.org/10.6004/jnccn.2022.0025
Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, et al. “Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 20, no. 5 (May 2022): 497–530. https://doi.org/10.6004/jnccn.2022.0025.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 May;20(5):497–530.
Ettinger, David S., et al. “Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 20, no. 5, May 2022, pp. 497–530. Pubmed, doi:10.6004/jnccn.2022.0025.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, DeCamp M, Dilling TJ, Dowell J, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Pacheco JM, Patel SP, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory K, Hughes M. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 May;20(5):497–530.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2022
Volume
20
Issue
5
Start / End Page
497 / 530
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Medical Oncology
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis